MBL Senior Scientist Joshua Rosenthal co-founded a company, Korro Bio, to explore the potential application to human therapeutics of RNA editing, which Rosenthal discovered occurs in cephalopods to an extraordinary degree. Below, Nature Biotechnology highlights Korro Bio as one of 10 biotech startups that are “pioneering cutting-edge approaches.”
By Michael Eisenstein, Ken Garber, Caroline Seydel & Laura DeFrancesco
The universe of life science ventures flourished last year. Some of the largest rounds of venture capital ever seen went into 2019 biotech startups. Several of these are profiled here, as are companies that are working with less capital but still breaking new ground.
As in previous years of our survey, we have focused on R&D-intensive startups spun out from academic institutions. … What follows are the stories behind the selected ventures and their offerings. Although our survey is by no means exhaustive, we believe these companies represent some of the best (and most handsomely financed) science that was commercialized from academia in 2019. Read more …
Photo: Joshua Rosenthal with Octopus bimaculoides in the MBL’s Marine Resources Center. Credit: Tom Kleindinst